Intellia Therapeutics Inc. is a leading biotechnology company specializing in the development of gene editing therapies. With a strong focus on CRISPR/Cas9 technology, they aim to revolutionize medicine by enabling precise and efficient editing of genetic material. Their innovative approach holds immense potential for treating a wide range of diseases.
Notification